Gilder Gagnon Howe & Co’s Imperva, Inc. IMPV Stock Holding History

Gilder Gagnon Howe & Co’s Portfolio IMPV Stock Details IMPV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q3	–	Sell	-111,390	Closed	-$5.33M	–	309
2017 Q2	$5.33M	Buy	+111,390	New	+$5.2M	0.08%	144
2014 Q2	–	Sell	-4,666	Closed	-$260K	–	327
2014 Q1	$260K	Sell	4,666 -1,200	-20%	-$69K	﹤0.01%	247
2013 Q4	$282K	Buy	5,866 +25	+0.4%	+$1.05K	﹤0.01%	235
2013 Q3	$245K	Sell	5,841 -106	-2%	-$5.05K	﹤0.01%	233
2013 Q2	$268K	Buy	+5,947	New	+$233K	0.01%	243

Other funds holding IMPV

Eminence Capital New York $4.36B AUM 3.1% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Elliott Management New York $11.8B AUM 20.29% 1-Year Est. Return

Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return

EAM

Eagle Asset Management St Petersburg, Florida $19.6B AUM 41.58% 1-Year Est. Return

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

EMG

ETF Managers Group Summit, New Jersey $3.1B AUM 17.12% 1-Year Est. Return

Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return

Gilder Gagnon Howe & Co's IMPV Position: Q3 2017 in Review

Gilder Gagnon Howe & Co sold out of Imperva, Inc. (IMPV) in Q3 2017, closing a stake of 111,390 shares — an estimated $5.33M sold.

Gilder Gagnon Howe & Co first reported a position in IMPV in Q2 2013 and held it in 5 quarters. The position peaked at $5.33M in Q2 2017. 171 funds tracked by Wall St. Rank hold IMPV as of Q3 2017.

Gilder Gagnon Howe & Co reported no remaining Imperva, Inc. position as of Q3 2017 after selling out during the quarter.
Gilder Gagnon Howe & Co sold 111,390 Imperva, Inc. shares in Q3 2017, an estimated $5.33M.
Gilder Gagnon Howe & Co first reported a position in Imperva, Inc. in Q2 2013 and held it in 5 quarters.
Gilder Gagnon Howe & Co's Imperva, Inc. position peaked at $5.33M in Q2 2017.
171 funds tracked by Wall St. Rank held Imperva, Inc. as of Q3 2017.

Based on Gilder Gagnon Howe & Co's 13F filing for Q3 2017, filed 6 Nov 2017.